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  Duplication of short-arm material from chromosome 
9 (or partial trisomy 9p) was first described by Rethore et 
al. [1970] and is now a well-described syndrome that has 
been documented in more than 150 patients [Rethore et 
al., 1970; Centerwall and Beatty-DeSana, 1975]. In most 
of these patients, the duplication 9p is a result of an ab-
normal chromosome segregation of a balanced translo-
cation in one of the parents [Baccichetti and Tenconi, 
1973; Wajntal et al., 1985].   De novo   duplications of this 
chromosomal region have been previously described in 
approximately 15 patients [Chiyo et al., 1976; Baccichetti 
et al., 1979; Fryns et al., 1979; Motegi et al., 1985; Mattina 
et al., 1987; Haddad et al., 1996; Fujimoto et al., 1998; 
Tsezou et al., 2000; Krepischi-Santos and Vianna-Mor-
gante, 2003]. Patients with partial trisomy of the short 
arm of chromosome 9 often display a wide spectrum of 
clinical symptoms including developmental delay, cra-
niofacial abnormalities (bulbous nose, hypertelorism, 
downward-slanting palpebral fissures), limb abnormali-
ties (short fingers and toes with small nails, fifth-finger 
clinodactyly) and skeletal malformations.
 Key  Words 
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 Abstract 
  Approximately 15 patients with partial trisomy 9p involving 
 de novo  duplications have been previously described. Here, 
we present clinical, cytogenetic, FISH and aCGH findings in 
a patient with a  de novo  complex rearrangement in the short 
arm of chromosome 9 involving an inverted duplication at 
9p24  ]  p21.3 and a deletion at 9pter  ]  p24.2. FISH probes 
g e n e r a t e d  f r o m  B A C s  s e l e c t e d  f r o m  t h e  U C S C  g e n o m e  
browser were utilized to verify this rearrangement. It is likely 
that some previously described duplications of 9p may also 
be products of complex chromosomal aberrations. This re-
port in which FISH and aCGH were used to more comprehen-
sively characterize the genomic rearrangement in a patient 
with clinical manifestations of 9p duplication syndrome un-
derscores the importance of further characterizing cytoge-
netically detected rearrangements. 
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    Here, we describe a patient with a   de novo   complex 
rearrangement of the short arm of chromosome 9, involv-
ing duplication and deletion of chromosomal material 
detected by GTG banding, characterized and delineated 
further by FISH and array CGH.
  C l i n i c a l   R e p o r t  
 A 4-month-old female infant was evaluated in the cra-
niofacial clinic for a complete cleft of the soft palate. She 
had difficulty in feeding with aspirations and related 
poor weight gain. She was born to a 25-year-old gravida 
III para II mother of mixed European descent and 21-
year-old father of English descent. Her mother presented 
late for prenatal care due to insurance issues. There were 
no reported exposures to medications, alcohol or tobac-
co. Prenatal ultrasound monitoring at an outside institu-
tion during the third trimester was notable for decreased 
growth, however, prenatal chromosome analysis was not 
performed. Vaginal delivery was induced 9 days prior to 
the due date without complications. Apgar scores were 9 
and 10 after 1 and 5 min. Birth weight was 2.414 kg (3rd 
  percentile for gestational age), head circumference was 33 
cm (25th percentile for gestational age), and length was 
45.7 cm (  !  3rd percentile for gestational age). Family his-
tory was unremarkable for cleft lip/palate or other birth 
defects, known chromosomal abnormalities and recur-
rent miscarriages. There was no known consanguinity. 
On examination, the patient was alert and active with a 
normal body habitus. Length, weight, and head circum-
ference at 4 months were 55.5 cm (2nd percentile), 4.83 kg 
(3rd percentile), and 39.4 cm (21st percentile), respective-
ly. Notable findings included the appearance of large, 
prominent deep set eyes with an interpupillary distance 
of 4.5 cm (50th–75th percentile) and an intercanthal dis-
tance of 2.6 cm (75th–97th percentile). Formal ophthal-
mology evaluation did not reveal macrocornea or other 
significant structural abnormalities. Additional findings 
included complete cleft of the soft palate, cupped but not 
low-set ears, bulbous nose, thin upper lip, small mouth 
and mild micrognathia. The remaining physical exami-
nation was notable for normal palmar creases, significant 
fifth-digit clinodactyly bilaterally, with only one 5th dig-
ital crease, dimpling of the elbows, and sacral dimples 
bilaterally. No murmurs were appreciated on the cardiac 
exam and the rest of the physical examination was unre-
markable (  fig. 1  A and B). At the initial encounter (age of 
4 months), appropriate developmental milestones had 
been achieved.
    The combination of the intrauterine growth retarda-
tion, dysmorphic facial features and cleft of the soft palate 
raised the possibility of a syndrome diagnosis. Blood was 
sent for chromosome analysis.
    The patient was seen at follow-up at 15 months of age. 
Interim history was notable for surgical repair of her cleft 
approximately 3 months prior to examination. At 15 
months, her development was delayed, as she was not able 
to sit unsupported for long periods of time. She was crawl-
ing but could not pull to a stand or cruise, and had lim-
ited vocalization.
  Further evaluation revealed a normal echocardiogram 
at 22 months, normal ophthalmology examination and 
moderate right-sided renal pelviectasis. New family his-
tory revealed a maternal second cousin with a cleft lip, but 
further details were not available. Length, weight, and 
AB
  Fig. 1.   Patient at 4 months of age.   A   Front 
view: note the large-appearing eyes, hy-
pertelorism, bulbous nose, thin vermilion, 
small-appearing mouth and subtle micro-
gnathia.   B   Clinodactyly of the 5th digit.    Female with   de novo   Complex 9p 
Rearrangement 
Cytogenet Genome Res 2009;126:305–312  307
head circumference were 73.5 cm (8th percentile), 9.4 kg 
(8th percentile), and 45.1 cm (12th percentile). In addition 
to the previously described features, her ears had devel-
oped a more cupped and floppy appearance, her big toes 
appeared broadened with dystrophic nails bilaterally, 
and there was mild hypotonia.
  Materials  and  Methods 
  Karyotyping and Fluorescence in situ Hybridization  
  Metaphase spread preparations from the patient and her par-
ents’ peripheral blood lymphocyte cultures and GTG-banding 
were performed according to standard methods. FISH was ini-
tially performed on the patient’s metaphase chromosomes using 
a whole chromosome 9 painting probe (Rainbow Scientific Inc., 
Windsor, Conn., USA) according to the manufacturer’s protocol. 
Additional FISH experiments were performed using BAC clones 
RP11-399M15 and RP11-32D4 (BACPAC Resources, Children’s 
Hospital Oakland Research Institute, Oakland, Calif., USA) and 
the TelVysion 9p probe (Abbott Molecular/Vysis, Inc., Downers 
Grove, Ill., USA). BAC DNA was isolated by standard procedures 
and direct-labeled with Spectrum Green and Spectrum Orange 
by nick translation (Abbott Molecular/Vysis, Inc.). Chromosomes 
were counterstained with 4’,6-diamidino-2-phenylindole (DAPI) 
and images were captured using the CytoVysion Imaging System 
(Applied Imaging, Pittsburg, Pa., USA).
    Array Comparative Genomic Hybridization 
  A human genome CGH Microarray 244K (Agilent Technolo-
gies, Inc., Santa Clara, Calif., USA) was used to define more pre-
cisely the duplicated and deleted chromosomal regions [Iafrate et 
al., 2004]. This array platform contains 236,000 60-mer oligonu-
cleotide probes spanning coding and noncoding genomic se-
quences with a median spacing of 7.4 kb and 16.5 kb, respectively. 
More than 99% of the genes on this array contain 3 or more probes 
and therefore a minimum of 3 consecutive probes was used as a 
cutoff for calling a genomic imbalance. The CGH analytics soft-
ware was used for aberration analysis and visualization, using the 
Aberration Detection Method algorithm, ADM2, to make the ge-
nomic imbalance calls. Probe sequence annotation was based on 
NCBI Build 36.1 (hg18) of the human genome. ‘Benign’ copy 
number variants were identified via the Database of Genomic 
Variants (  http://projects.tcag.ca/variation/)   based on informa-
tion deposited as of November 20, 2008.
  R e s u l t s  
  Karyotype and Fluorescence in situ Hybridization 
  Based on GTG-banding analysis, an inverted duplica-
tion was detected between bands p21 and p23 on chro-
mosome 9, and since parental karyotypes were both
normal, the patient’s karyotype was designated as 
46,XX,dup(9)(p23p21)dn (  fig. 2  A). FISH analysis using a 
whole chromosome 9 painting probe confirmed that the 
extrachromosomal material was of chromosome 9 origin. 
The suspected inversion of the duplicated segment and the 
deletion revealed by aCGH were confirmed by FISH using 
RP11-399M15 and RP11-32D4 BAC clones and a TelVy-
sion 9p probe as shown in   fig. 2  B and C. FISH performed 
on parental chromosomes revealed a normal hybridiza-
tion pattern with no evidence of cryptic inversion.
    Array Comparative Genomic Hybridization 
  Oligonucleotide-based array CGH confirmed and 
precisely delineated the observed duplication and addi-
tionally revealed a deletion on the short arm of chromo-
some 9 (  fig. 3  ). The deleted region begins at the 9pter-
most informative probe on the array (at nucleotide posi-
tion 194,193; 9p24.3) and extends proximally to 
nucleotide 3,745,031 (9p24.2). The duplicated region be-
gins at nucleotide 3,761,025 (9p24.2) and continues prox-
i m a l l y  t o  n u c l e o t i d e  2 0 , 1 1 1 , 6 3 3  ( 9 p 2 1 . 3 ) .  T h i s  c o r r e -
sponds to a deletion of at least 3.55 Mb in size and a du-
plication of at least 16.35 Mb in size. No known genes 
were identified at the breakpoints and no significant du-
plications (i.e.,   1  1000 bp) were observed within 1 Mb 
upstream and downstream of the duplication break-
points. A list of genes mapped to the duplicated and de-
leted regions is included in online supplementary table 1 
(www.karger.com/doi/10.1159/000251966).
nl 9 nl 9 del(9) nl 9 dup(9) dup(9)
A
BC
  Fig. 2.   Partial karyotype of the patient showing the normal (left) 
and the abnormal (right) chromosome 9.   A  GTG banding.  B  FISH 
with the RP11-399M15 probe (spectrum green) and the RP11-
32D4 probe (spectrum orange). Note the duplication and reverse 
orientation of the hybridization signals on the abnormal chromo-
some 9.   C   FISH with the Tel9p probe (spectrum green) and the 
CEP9 probe (spectrum orange) demonstrating deletion on the ab-
normal chromosome 9.   Hulick   /Noonan   /Kulkarni   /Donovan   /
Listewnik    /Ihm   /Stoler   /Weremowicz   
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  Discussion 
 Duplication of 9p is well described in the scientific lit-
erature with more than 150 patients reported. However, 
most of these reported duplications are due to malsegre-
gation of chromosomes inherited from a parent with a 
reciprocal translocation involving chromosome 9, with 
relatively few pure 9p duplications arising de novo [Chiyo 
et al., 1976; Baccichetti et al., 1979; Fryns et al., 1979; Mo-
tegi et al., 1985; Mattina et al., 1987; Haddad et al., 1996; 
Fujimoto et al., 1998; Tsezou et al., 2000; Bonaglia et al., 
2002; Krepischi-Santos and Vianna-Morgante, 2003; 
Swinkels et al., 2008]. Despite varying sizes of duplicated 
chromosomal segments, there is a significant overlap in 
clinical features in duplication 9p syndrome, which is at-
tributed to the terminal segment of 9p. The characteristic 
facial features include microcephaly, enophthalmos, hy-
pertelorism, antimongoloid slant of palpebral fissures, 
micrognathia, broad nasal root with bulbous nasal tip, 
downturned corners of the mouth, and anomalous ears 
[Haddad et al., 1996; Fujimoto et al., 1998]. Other distinc-
tive trisomy 9p manifestations reported are psychomotor 
retardation, growth retardation, hypotonia, strabismus, 
myopia, short neck, brachymesophalangy, and small 
hands and feet. We reviewed the findings of patients with 
  de novo   9p duplication (no other cytogenetic abnormali-
ties), and compared the findings with our patient (  ta-
ble 1 ). The phenotype of our patient is similar to the mal-
formation spectrum frequently described in other pa-
tients with partial trisomy 9p (  fig. 1  A and B). However, 
some features noted in our patient differed from previ-
ously described patients with duplication 9p, such as the 
cleft palate and large eyes. Therefore to better character-
ize the chromosome 9 abnormality, conventional cytoge-
netics was supplemented with FISH on metaphase chro-
mosomes and oligonucleotide-based aCGH.
    The aCGH-based analysis defined more precisely the 
location and size of the duplication and revealed an un-
expected 3.55-Mb terminal 9p deletion. Patients with de-
letion 9p have been characterized both clinically and cy-
togenetically. Alfi et al. [1976] described the first series of 
patients and others have further characterized the dis-
tinctive features of trigonocephaly, midface hypoplasia, 
upward-slanting palpebral fissures, and a long philtrum. 
Our patient did not have all of these characteristic fea-
tures (  table 2  ), and this could be due to the fact that her 
deletion does not include what is thought to be the critical 
region at 9p22 responsible for the classical 9p deletion 
phenotype [Alfi et al., 1973, 1976; Huret et al., 1988; Christ 
et al., 1999; Kawara et al., 2006; Swinkels et al., 2008].
  A complex  de novo  rearrangement of 9p involving du-
plication and deletion has been characterized by GTG 
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  Fig. 3.   Oligonucleotide aCGH results of chromosome 9 in a patient with 9p duplication and deletion. The dele-
tion is shown with red arrows on the upper side and duplication is shown with blue arrows on the lower side.                Female with   de novo   Complex 9p 
Rearrangement 
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Table 1. Clinical features and chromosome breakpoints in patients with de novo pure 9p duplication.
Authors Duplication Congenital anomalies
Our patient p21.3–p24.2 
Inverted
Cleft palate, absent uvula, difficulty with feeding, poor weight gain, clinodactyly, dystrophic nails, 
growth retardation, developmental delay, large palpebral fissures, hypertelorism, bulbous nose, cup- 
shaped ears, mild micrognathia and hypotonia
Baccichetti et al.
(1979)
p21–p24 
Inverted
Mild mental retardation, short stature, lip anomalies, microcephaly, hypertelorism, malformed 
ears, antimongoloid slant, bulbous nose, clinodactyly, single palmar crease
Bonaglia et al.
(2002)
p13.1–p22.1 Dolichocephaly, crowded teeth, high-arched palate, mild ear length asymmetry, normal intelli-
gence
Bussani et al.
(1991)
p12–p22 Developmental delay, down-slanting palpebral fissures, bulbous nose, downturned corners of the 
mouth, cup-shaped ears, short neck, transverse palmar crease, 5th-digit clinodactyly
Chiyo et al.
(1976)
p21–p24 
Inverted
Severe mental retardation, microcephaly, hypertelorism, malformed ears, antimongoloid slant, bul-
bous nose, clinodactyly, single palmar crease, nail hypoplasia
Fryns et al.
(1979)
p13–p22 Developmental delay, high forehead, large anterior fontanel/widened metopic suture, hyper-
telorism, large bulbous nose, short upper lip, large mouth with downturned corners, low-set ears, 
small hands/feet, hypotonia, hyperlaxicity, clinodactyly, dystrophic nails
Fujimoto et al.
(1998)
p22–p24 
Tandem
Mental retardation, short stature, lip anomalies, malformed ears, antimongoloid slant, bulbous 
nose
Guanciali et al.
(2000)
p22–p24 Microcephaly, hypotonia, deep-set eyes with hypertelorism, down-slanting palpebral fissures, 
wide/short neck, low-set and malformed ears, wide/prominent nose with wide philtrum, single pal-
mar crease
Haddad et al.
(1996)
p22–p22 
Tandem
Mild mental retardation, short stature, lip anomalies, microcephaly, malformed ears, antimongol-
oid slant, bulbous nose, clinodactyly
Krepischi-
Santos et al.
(2003)
Multiple
patients
Developmental delay, microcephaly, frontal bossing, low-set frontal hairline, facial hirsutism, hy-
pertelorism, deep-set and downslanting eyes, epicanthus, bulbous nose, short philtrum, down-
turned corners of the mouth, small teeth, retrognathia, large/protruding ears with overfolded heli-
ces, hypoplastic middle phalanges, hypoplastic nails, clinodactyly, single interphalangeal flexion 
crease of the fifth finger, bilateral single transverse creases, absent palmar triradii c, cryptorchidism, 
scoliosis
Motegi et al.
(1985)
p12–p24 
Tandem
Brachycephaly, microcephaly, large anterior fontanelle, hypertelorism, asymmetry and antimon-
goloid slant of the palpebral fissures, prominent nasal bridge, bulbous nose, cleft lip and palate, 
downturned corners of the mouth, cup-shaped ears, small hands and feet with hypoplastic nails, 
left cryptorchidism, incomplete simian creases, brachymesophalangy with fusion of flexion creases, 
clinodactyly
Sanlaville et al.
(1999)
p21–pter 
Tandem
Mild mental retardation, enophthalmos, antimongoloid slant, lip anomalies, bulbous nose, clino-
dactyly, single palmar crease
Temtamy et al.
(2007)
p21–p24 Patients 2 and 3 – developmental delay, brachycephaly, hypertelorism, downslanting eyes, bulbous 
nose, short/deep philtrum, downturned corners of the mouth, macrostomia, low-set ears, short 
neck, aplasia/hypoplasia of terminal phalanges, clinodactyly, broad hallux, nail hypoplasia
Tsezou et al.
(2000)
p12–p24 
Tandem 
Inverted
Patient 1 – brachycephaly, high forehead, hypertelorism, epicanthus, deep-set eyes, bulbous nose, 
thin upper lip, downturned corners of the mouth, cup-shaped ears, micro-/retrognathia, short 
broad neck, widely spaced nipples, single palmar crease, syndactyly of the 3rd–4th fingers and 2nd–
4th toes’ hypoplastic nails, developmental delay
Patient 2 – developmental delay, brachycephaly, frontal bossing, hypertelorism, epicanthus, deep-
set eyes, strabismus, bulbous nose, short upper lip, downturned corners of the mouth, cup-shaped 
ears, short broad neck, widely spaced nipples, short thumbs, single palmar creases
Bolding represents features in common with our patient. Hulick   /Noonan   /Kulkarni   /Donovan   /
Listewnik    /Ihm   /Stoler   /Weremowicz   
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banding and FISH in 1 patient [Teebi et al., 1993]. A sim-
ilar rearrangement has been recently investigated by rou-
tine cytogenetics and FISH as well as aCGH in 2 other 
patients [Swinkels et al., 2008]. These 3 patients and our 
case shown in   table 3   clearly illustrate that rearrange-
ments in this area of 9p may be more complex than orig-
inally assessed by routine cytogenetics. The phenotype of 
these 2 patients for whom the breakpoints and size of the 
dup/del have been precisely defined by aCGH differs 
from that of our patient and was more similar to the 9p 
deletion phenotype [Swinkels et al., 2008]. This is most 
likely because they carry larger deletions involving 9p22 
and duplications with more proximal breakpoints (at p12 
and p13.3). The region of overlap between the former
2 patients and our patient appears to be limited to 
9p22.3  ]  p21.3. Since the structural configuration of the 
abnormal chromosome could not be determined from 
the aCGH results, FISH on metaphase chromosomes 
with selected BAC clones was utilized to establish the ori-
entation of the rearranged segment and to evaluate the 
parental chromosomes to rule out the possibility of a 
cryptic inversion. Precise characterization of any struc-
tural chromosome abnormality is important because the 
nature of it may affect a clinical manifestation in the car-
rier due to possible gene disruption, creation of a chime-
ric transcript and/or position effect. It also may shed light 
on the mechanism of the rearrangement as well as to aid 
genetic counseling and possible recurrence risk evalua-
tion. Our proband’s parental karyotypes were apparently 
normal based on both GTG and FISH analysis. There-
fore, the rearrangement in our patient is considered a   de 
novo   event, and given that there is no evidence for the 
presence of low-copy repeats known to lead to recurrent 
structural rearrangements by nonallelic homologous re-
combination, there is no increase in recurrence risk for 
this couple [Lupski and Stankiewicz, 2005]. Nonhomolo-
gous end joining mechanism has been considered as a 
mechanism for 9p dup/del as previously described [Chab-
choub et al., 2007]. It was postulated that this rearrange-
ment was facilitated by homologous LINE sequences 
identified at breakpoints on the short arms of chromo-
some 9 and chromosome 5 with a subsequent end healing 
by neo-telomere formation and chromosome 5 telomere 
capture on the der(9) chromosomes. Based on our aCGH 
and FISH results there is no evidence of exchange of ma-
terial between the abnormal chromosome 9 and any oth-
er chromosome in our patient. 9p rearrangements with 
scattered breakpoints have been described previously 
[Christ et al., 1999; Jehee et al., 2005], and rearrange-
ments involving inverted dup/del have been reported for 
other chromosomes. Several mechanisms leading to such 
rearrangements were hypothesized, however the causes 
still remain unclear [Bonaglia et al., 2000; Krepischi-San-
tos and Vianna-Morgante, 2003]. Elucidation of the 
mechanism involved in our patient’s rearrangement 
would require extensive molecular workup which is be-
yond the scope of this report.
    Based on the UCSC database there are 45 genes anno-
tated to the deleted and duplicated regions in our patient 
(online suppl.   table  1  ). From the deleted region, the 
  DMRT1, 2  , and   3   genes are known to be critical for sexu-
al determination and development. There is evidence for 
Table 2. Clinical features and chromosome breakpoints in patients with 9p deletion
Authors Deletion Congenital anomalies
Our patient p24.2–pter Cleft palate, absent uvula, difficulty with feeding, poor weight gain, clinodactyly, dystrophic nails, 
growth retardation, developmental delay, large palpebral fissures, hypertelorism, bulbous nose, cup- 
shaped ears, mild micrognathia and hypotonia
Livadas et al.
(2003)
p22 Developmental delay, hypertelorism, depressed nasal bridge, low-set/dysmorphic ears, sex reversal
Ogata et al.
(1997)
p23–pter Prominent forehead, anteverted nostrils, low-set ears, high/arched palate, micrognathia, puffy hands 
and feet, funnel chest, microphallus, hypospadias, hypoplastic scrotum, ambiguous genitalia
Swinkels et al.
(2008)
Multiple
patients
Major features: mental retardation, trigonocephaly, midface hypoplasia, long philtrum
Other features: developmental delay, hypertelorism, epicanthal folds, small palpebral fissures, flat 
nasal bridge, anteverted nares, posteriorly rotated and low-set ears, micrognathia, microstomia, short, 
neck, widely spaced nipples, hypotonia, nail abnormalities
Bolding represents features in common with our patient.  Female with   de novo   Complex 9p 
Rearrangement 
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haploinsufficiency of these genes, as a result of distal 9p 
monosomy, resulting in a dosage-dependent mechanism 
for abnormal testicular and ovarian development in oth-
erwise karyotypically normal males and females [Mu-
roya et al., 2000; Shan et al., 2000; Livadas et al., 2003]. 
Although at least two 46,XX,del(9p) females reportedly 
had normal pubertal development [Ounap et al., 2004], 
close monitoring for impaired pubertal development and 
ovarian dysfunction is reasonable. Disruption of the 
  DOCK8   gene was reported in 2 unrelated patients with 
mental retardation and developmental disabilities [Griggs 
et al., 2008]. Loss of   ANKRD15   gene resulting from a 
common 225-kb deletion at 9p24.3 was identified in 9 
children with congenital cerebral palsy . Based on evi-
dence that   ANKRD15   is maternally imprinted, deletion 
of the paternal copy could have clinical implications [Le-
rer et al., 2005]. We do not know the relevance of this gene 
to our patient as the parental origin of her abnormal 
chromosome 9 is unknown.
  Although we are not able to define any specific contri-
bution of the duplicated genes to the phenotype of our 
patient or to predict potential future complications, it is 
plausible to assume that altered copy number of genes 
mapped to the duplicated region (e.g.   JAK2   gene) whose 
role is well documen ted in man y signaling/ regulation 
pathways (i.e. fat metabolism, body growth) may affect 
the phenotype and contribute to future complications in 
our patient [Kaushansky, 2005].
    To our knowledge,   de novo   duplication/deletion of 9p 
has been precisely characterized by employing routine 
cytogenetics, FISH, BAC aCGH [Swinkels et al., 2008] 
and oligonucleotide aCGH (our case) in only 3 patients. 
It is quite conceivable that some of the previously report-
ed patients with rearrangements of 9p have more com-
plex aberrations with concomitant deletions and duplica-
tions undetected by conventional chromosome banding 
and FISH. Fully characterizing these complex rearrange-
ments may provide clues to the clinical manifestations of 
the genes in the affected region, as in our patient, the 
genes in the region of duplication/deletion have not been 
associated with cleft palate. Such studies with full mo-
lecular characterization of cytogenetic findings in pa-
tients with duplication/deletions are important to better 
understand phenotype-karyotype correlations and to de-
fine critical regions for identification of candidate 
genes.
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Table 3. Clinical features and chromosome breakpoints in patients with pure de novo 9p deletion and duplication
Authors Deletion and duplication Congenital anomalies
Our Patient del p24.2–pter 
dup p21.3–p24 
Inverted
Cleft palate, absent uvula, difficulty with feeding, poor weight gain, clinodactyly, dys-
trophic nails, growth retardation, developmental delay, large palpebral fissures, hyper-
telorism, bulbous nose, cup-shaped ears, mild micrognathia and hypotonia
Swinkels et al.
(2008)
del p22.2–pter 
dup p13.3–p22.2 
Inverted 
and 
del p22.3–pter 
dup p12–p22.3 
Inverted
Developmental delay, trigonocephaly, midface hypoplasia, low-set and posteriorly ro-
tated ears, micro-/retrognathia, tapering fingers, cardiac murmur/deficit, omphalo-
cele
Teebi et al.
(1993)
del p22–pter 
dup p13–p22 
Inverted
Developmental delay, microcephaly, narrow forehead with metopic ridging, midface 
hypoplasia, long tapering fingers, clinodactyly, hypotonia, small nose
Bolding represents features in common with our patient. Hulick   /Noonan   /Kulkarni   /Donovan   /
Listewnik    /Ihm   /Stoler   /Weremowicz   
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